Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $23.9300 (-1.89%) ($23.9300 - $23.9300) on Mon. Nov. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.75% (three month average) | RSI | 24 | Latest Price | $23.9300(-1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -2.3% a day on average for past five trading days. | Weekly Trend | TGTX declines -13.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(70%) ARKG(66%) IBB(63%) ARKK(61%) IWO(60%) | Factors Impacting TGTX price | TGTX will decline at least -1.875% in a week (0% probabilities). VIXM(-49%) VXX(-40%) UUP(-19%) UNG(-7%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.875% (StdDev 3.75%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.34(-73.51%) | Resistance Level | $30.63 | 5 Day Moving Average | $25.36(-5.64%) | 10 Day Moving Average | $28.42(-15.8%) | 20 Day Moving Average | $30.63(-21.87%) | To recent high | -32.7% | To recent low | 0% | Market Cap | $3.031b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |